Therapeutic Potential of the Dual Peroxisome Proliferator Activated Receptor (PPAR)/ Agonist Aleglitazar in Attenuating TNF-mediated Inflammation and Insulin Resistance in Human Adipocytes: A Review
Asian Journal of Immunology · pp. 34–44 · Published 10 Dec 2019
Abstract
Aleglitazar, is a novel promising drug, that related to peroxisome proliferator-activated receptor (PPARα&γ) agonists which shows an ant-diabetic and anti-inflammatory characteristics. The goal of this study is to evaluate anti-inflammatory and anti-arthritic properties of Aleglitazar in arthritis models induced in experimental animals and to conclude the comparative ulcerogenic potential of diclofenac in type 2 diabetes animals. The anti-inflammatory characteristics of Aleglitazar will be investigated in Carrageenan-induced hind paw edema as acute inflammation. The Aim of the review: This study aims to assess anti-inflammatory and anti-arthritic activities of aleglitazar in arthritis models induced in experimental animals. It is to determine comparative ulcerogenic potential diclofenac in type 2 diabetic animals on gastric mucosa in rats.
Cited by 0
No indexed citations yet.
Related research
- Expression of Cytokines in Vaginal Secretion of Women with Yeast Colonization — shares topic coverage
- Anti-inflammatory Activity of the Phenolic-rich Extract of Schotia brachypetalea Sond. Fam. Fabaceae, Cultivated in Egypt — shares topic coverage
- Malaria in Pregnancy Induces a Pro-inflammatory Cytokine Milieu: Comparative Analysis with Non-infected Pregnant and Non-pregnant Women — shares topic coverage
- Peroxisome Proliferator-Activated Receptor-Review — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.